Home Mf Research Sbi Healthcare Opportunities Fund Regular Plan Growth
SBI Mutual Fund

Mutual Fund Research

SBI Healthcare Opportunities Fund - Regular Plan - Growth

Fund Performance

-
-
Historical NAV
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • SI

SIP Returns

Historical performance of a ₹1,000 monthly SIP

Historical data
Investment Period SIP Start Date Amount Invested Current Value Absolute Return
One Week 2026-10-27 ₹1,000.00 ₹1,030.07 +3.01%
Two Week 2026-10-19 ₹1,000.00 ₹1,056.93 +5.69%
One Month 2026-10-05 ₹1,000.00 ₹1,022.67 +2.27%
Three Months 2026-08-05 ₹3,000.00 ₹2,990.72 -0.31%
Six Months 2026-05-07 ₹6,000.00 ₹6,224.92 +3.75%
One Year 2025-11-03 ₹12,000.00 ₹13,499.05 +12.49%
Three Year 2023-11-06 ₹36,000.00 ₹46,017.58 +27.83%
Five Year 2021-11-04 ₹60,000.00 ₹100,485.39 +67.48%
Ten Year 2016-11-07 ₹120,000.00 ₹327,410.82 +172.84%
Since Inception 2005-10-28 ₹256,000.00 ₹1,889,607.08 +638.13%

Past returns are historical, not guaranteed. SIP values depend on the dates and NAVs used.

Return Calculator

Explore SIP and one-time investment scenarios

₹1,000₹50,000
Investment Duration

Projection uses the selected fund return as an annualized assumption. It does not predict future performance.

Estimated Investment Summary

Investment
₹0
Maturity Value
₹0
Abs. Returns
₹0
Assumed Annual Return
0%

Illustrative values only. Market returns are not fixed or guaranteed.

Portfolio Allocation

Explore asset allocation, sector exposure and company holdings.

Equity
N/A
Debt
N/A
Others
N/A

Sector Allocation

Distribution across different sectors

Pharmaceuticals & Biotechnology 63.10%
Healthcare Services 25.64%
Chemicals & Petrochemicals 4.96%
Other 4.43%
Healthcare Equipment & Supplies 1.82%
Sovereign 0.05%

Top Holdings

Company-wise portfolio exposure

Sun Pharmaceutical Industries Ltd. 11.14%
Divi's Laboratories Ltd. 7.91%
Acutaas Chemicals Ltd. 5.03%
Apollo Hospitals Enterprise Ltd. 4.45%
Torrent Pharmaceuticals Ltd. 4.42%
Cipla Ltd. 4.40%
Laurus Labs Ltd. 4.05%
Max Healthcare Institute Ltd. 3.80%
Aurobindo Pharma Ltd. 3.42%
Aster DM Quality Care Ltd. 3.21%
Gland Pharma Ltd. 2.96%
Sudeep Pharma Ltd. 2.79%
Anthem Biosciences Ltd. 2.75%
Sai Life Sciences Ltd. 2.60%
Corona Remedies Ltd. 2.43%
Biocon Ltd. 2.37%
Fortis Healthcare Ltd. 2.36%
Concord Biotech Ltd. 2.25%
Aether Industries Ltd. 2.17%
Jupiter Life Line Hospitals Ltd. 2.16%
Polymedicure Ltd. 1.82%
Ajanta Pharma Ltd. 1.79%
Global Health Ltd. 1.74%
Mankind Pharma Ltd. 1.71%
Healthcare Global Enterprises Ltd. 1.70%
Krishna Institute of Medical Sciences Ltd. 1.69%
Cohance Lifesciences Ltd. 1.66%
Innova Captab Ltd. 1.65%
Dr. Lal Path labs Ltd. 1.62%
Nephrocare Health Service Pvt. Ltd. 1.12%
Syngene International Ltd. 1.12%
Rainbow Children's Medicare Ltd. 0.67%
Gufic Biosciences Ltd. 0.29%
Abbott India Ltd. 0.23%
Novartis India Ltd. 0.04%
364 DAY T-BILL 19.11.26 0.05%
TREPS 6.42%
Net Receivable / Payable -1.99%

Risk Ratios & Analysis

Understand the fund’s volatility, benchmark exposure and redemption characteristics.

σ
Standard Deviation
14.76%
Return volatility
β
Beta
0.85
Benchmark sensitivity
S
Sharpe Ratio
1.07
Risk-adjusted return
↗
Lock-in Period
N/A
Redemption restriction
◷
Residual Maturity
N/A
Time to maturity

Scheme Riskometer

Published risk classification for this scheme

Principal risk level

Investors understand that their principal will be at

Very High Risk

Low
Low to Moderate
Moderate
Moderately High
High
Very High

Riskometer is a scheme risk classification, not a prediction of future performance.

Fund Family

Compare schemes from SBI Mutual Fund by performance, fundamentals and risk.

Returns are historical and do not guarantee future performance.

View All SBI Mutual Fund Funds

Scheme Objective

The investment mandate and purpose of this scheme

The investment objective of the Scheme is to provide the investors with the opportunity of long term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.There is no assurance that the investment objective of the Scheme will be achieved.

Scheme Details

Investment requirements and key fund information

Fund Information

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio (Regular)
1.99%
Expense Ratio (Direct)
1.01%
Lock-in Period
N/A
Fund Age
N/A
Benchmark
BSE HEALTHCARE

Exit Load

Charges that may apply when you redeem units

For exit within 15 Days from the date of allotment - 0.50%; For exit after 15 Days from the date of allotment - Nil.

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?